Mozambique: Over 3,000 Patients Under New TB Combined Therapy

[AIM] Maputo -- 3,413 patients across Mozambique are undertaking the new tuberculosis preventive therapy, coupling strong doses of isoniazid (H) and rifapentine (P), to prevent simple and non-contagious cases from worsening and increasing the number of infected people.
Source: AllAfrica News: Tuberculosis - Category: Infectious Diseases Source Type: news